Image may be NSFW.
Clik here to view.
Clik here to view.
Cynapsus wins Michael J. Fox grant for study
Cynapsus Therapeutics (TSX-V:CTH) has been awarded a grant of $947,925 from the Michael J. Fox Foundation for Parkinson’s Research to support clinical studies to develop APL-130277, an oral thin film...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Cynapsus reports positive study data for APL-130277
Cynapsus Therapeutics (OTCQX:CYNAF; TSX-V:CTH) has released positive data from its recently completed CTH-104 healthy volunteer pilot study of a single, 25-milligram sublingual strip (APL-130277) dose...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Cynapsus posts positive top-line PD results
Cynapsus Therapeutics (OTCQX:CYNAF; TSX-V:CTH) has released positive top-line results from its CTH-105 Phase 2 clinical trial of APL-130277 for the management of OFF motor symptoms of Parkinson’s...
View Article
More Pages to Explore .....
